A study suggests twice-yearly Yeztugo offers HIV prevention without adversely affecting gender-affirming care.
In a large clinical trial assessing Apretude, ViiV Healthcare’s recently approved injectable drug, as a form of HIV prevention, seven participants contracted the virus despite receiving their ...
Pharmaceutical Technology on MSN
UK approves Gilead’s twice-yearly HIV PrEP drug
Gilead Sciences’ pre-exposure prophylaxis (PrEP) formula of lenacapavir has been approved in the UK as a preventative option ...
A daily preventive pill can be invaluable for people at risk for HIV. But some doctors don't know much about prescribing them. And billing headaches are common. Here's how to overcome those hurdles.
The U.S. Food and Drug Administration has approved a highly effective HIV prevention drug that outperforms oral medications in stopping HIV transmission. Developed by Gilead Sciences, the drug ...
A twice-a-year injectable drug has been shown to be 100% effective in preventing the spread of HIV, according to the first data from a clinical trial. If approved, the drug offers another preventive ...
Dallas resident Clint Hassell comes to the Fort Worth location of the HELP Center for LGBT Health & Wellness for free PrEP services. He started taking the PrEP medicine around two years to reduce the ...
It’s possible to produce a generic version of lenacapavir, a twice-yearly antiretroviral injection that both prevents and treats HIV, for as little as $25 per patient per year, according to a study ...
When Dr. Sharon Nachman treats teenagers or young adults, she often asks about their sexual health and whether they would consider a medication that can vastly improve the chances of avoiding an HIV ...
When Nicklaus Chalk started law school at the University of California, Berkeley, last fall, one of his top priorities was to take care of his health. The 24-year-old student visited a doctor to get a ...
It’s been over a decade since the Food and Drug Administration first approved a medication to prevent HIV. But the Centers for Disease Control and Prevention estimates just 30% of the 1.2 million ...
HIV rates are up in Atlanta. Activists and Georgia politicians say this doesn’t have to happen because cheap and safe medicines known as PrEP are over 99% effective at blocking the infection when ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results